文献速递呼吸衰竭与机械通气儿科与产科急症

3 L/kg/min与2 L/kg/min高流量鼻导管流量在重症病毒性细支气管炎婴儿中的多中心随机对照试验(TRAMONTANE 2)

A multicenter randomized controlled trial of a 3-L/kg/min versus 2-L/kg/min high-flow nasal cannula flow rate in young infants with severe viral bronchiolitis (TRAMONTANE 2).
PubMed 文献 · Intensive Care Med · 2018-10-21
一句话结论在重症病毒性细支气管炎婴儿中,3 L/kg/min高流量鼻导管流量较2 L/kg/min未降低48小时内治疗失败风险,且不适更常见、PICU住院更长。

本研究为16个儿科ICU参与的多中心随机对照试验,纳入6月龄以下中重度急性病毒性细支气管炎并接受高流量鼻导管治疗的婴儿,比较2 L/kg/min与3 L/kg/min两种流量。主要终点为随机后48小时内治疗失败率,2L组38.7% vs 3L组38.9%(p=0.98),无显著差异。3L组不适更常见(43% vs 16%,p=0.002),PICU住院更长(6.4 vs 5.3天,p=0.048)。插管率、有创及无创通气时长两组无显著差异,无患者发生漏气综合征或死亡。作者结论认为3 L/kg/min未降低失败风险。

要点

  • 在6月龄以下中重度急性病毒性细支气管炎婴儿中,3 L/kg/min较2 L/kg/min未降低48小时内治疗失败率(38.9% vs 38.7%,p=0.98)。
  • 3L组不适更常见(43% vs 16%,p=0.002),PICU住院时间更长(6.4 vs 5.3天,p=0.048)。
  • 插管率(3L组6.9% vs 2L组2.8%,p=0.17)及有创、无创通气时长两组无显著差异。
  • 两组均无患者发生漏气综合征或死亡。
  • 作者结论:在急性病毒性细支气管炎婴儿高流量鼻导管支持中,3 L/kg/min未降低失败风险。

适用人群与场景

  • 6月龄以下中重度急性病毒性细支气管炎并接受高流量鼻导管治疗的婴儿,来自16个儿科ICU。

诊断标准与关键阈值

  • 主要终点失败判定使用预设的呼吸窘迫加重和不适标准。

处置流程与药物剂量

  • 高流量鼻导管流量设置:2 L/kg/min或3 L/kg/min。

研究设计与关键结果

  • 多中心随机对照试验,16个儿科ICU,2016年11月至2017年3月,2L组142例、3L组144例。
  • 48小时内治疗失败率:2L组38.7% vs 3L组38.9%(p=0.98)。
  • 呼吸窘迫加重为两组最常见失败原因:2L组49% vs 3L组39%(p=0.45)。
  • 3L组不适更常见:43% vs 16%(p=0.002);PICU住院更长:6.4 vs 5.3天(p=0.048)。
  • 插管率:2L组2.8% vs 3L组6.9%(p=0.17);有创通气时长:2L组0.2天 vs 3L组0.5天(p=0.10);无创通气时长:2L组1.4天 vs 3L组1.6天(p=0.97)。
  • 无患者发生漏气综合征或死亡。

证据类型、等级与局限

  • 证据类型:多中心随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于6月龄以下中重度急性病毒性细支气管炎婴儿,3 L/kg/min高流量鼻导管流量较2 L/kg/min未降低48小时内治疗失败风险,且3L组不适更常见、PICU住院更长;插管率、有创及无创通气时长两组无显著差异。
  • 作者结论认为3 L/kg/min未降低失败风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: High-flow nasal cannula (HFNC) therapy is increasingly proposed as first-line respiratory support for infants with acute viral bronchiolitis (AVB). Most teams use 2 L/kg/min, but no study compared different flow rates in this setting. We hypothesized that 3 L/kg/min would be more efficient for the initial management of these patients.

METHODS: A randomized controlled trial was performed in 16 pediatric intensive care units (PICUs) to compare these two flow rates in infants up to 6 months old with moderate to severe AVB and treated with HFNC. The primary endpoint was the percentage of failure within 48 h of randomization, using prespecified criteria of worsening respiratory distress and discomfort.

RESULTS: From November 2016 to March 2017, 142 infants were allocated to the 2-L/kg/min (2L) flow rate and 144 to the 3-L/kg/min (3L) flow rate. Failure rate was comparable between groups: 38.7% (2L) vs. 38.9% (3L; p = 0.98). Worsening respiratory distress was the most common cause of failure in both groups: 49% (2L) vs. 39% (3L; p = 0.45). In the 3L group, discomfort was more frequent (43% vs. 16%, p = 0.002) and PICU stays were longer (6.4 vs. 5.3 days, p = 0.048). The intubation rates [2.8% (2L) vs. 6.9% (3L), p = 0.17] and durations of invasive [0.2 (2L) vs. 0.5 (3L) days, p = 0.10] and noninvasive [1.4 (2L) vs. 1.6 (3L) days, p = 0.97] ventilation were comparable. No patient had air leak syndrome or died.

CONCLUSION: In young infants with AVB supported with HFNC, 3 L/kg/min did not reduce the risk of failure compared with 2 L/kg/min. This clinical trial was recorded on the National Library of Medicine registry (NCT02824744).

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Milési C, Pierre AF, Deho A, et al. A multicenter randomized controlled trial of a 3-L/kg/min versus 2-L/kg/min high-flow nasal cannula flow rate in young infants with severe viral bronchiolitis (TRAMONTANE 2). Intensive Care Med. 2018. PMID: 30343318. doi:10.1007/s00134-018-5343-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。